Nelarabine 25021-0259
Product NDC
25021-0259- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 1, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA212605
Need to source Nelarabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Nelarabine | 5 mg/mL |
Drug Class
Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Packaging Options(2)
1 VIAL in 1 CARTON (25021-259-50) / 50 mL in 1 VIAL
6 VIAL in 1 CARTON (25021-259-51) / 50 mL in 1 VIAL